These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30677223)

  • 1. An integrative systems approach identifies novel candidates in Marfan syndrome-related pathophysiology.
    Bhushan R; Altinbas L; Jäger M; Zaradzki M; Lehmann D; Timmermann B; Clayton NP; Zhu Y; Kallenbach K; Kararigas G; Robinson PN
    J Cell Mol Med; 2019 Apr; 23(4):2526-2535. PubMed ID: 30677223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients.
    Yin 殷晓科 X; Wanga S; Fellows AL; Barallobre-Barreiro J; Lu R; Davaapil H; Franken R; Fava M; Baig F; Skroblin P; Xing Q; Koolbergen DR; Groenink M; Zwinderman AH; Balm R; de Vries CJM; Mulder BJM; Viner R; Jahangiri M; Reinhardt DP; Sinha S; de Waard V; Mayr M
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1859-1873. PubMed ID: 31315432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
    Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W
    J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
    Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
    Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and sex-specific biomechanics and extracellular matrix remodeling of the ascending aorta in a mouse model of severe Marfan syndrome.
    Dwivedi KK; Rother J; Wagenseil JE
    Am J Physiol Heart Circ Physiol; 2024 Oct; 327(4):H1037-H1051. PubMed ID: 39212766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Type-Specific Contributions of the Angiotensin II Type 1a Receptor to Aorta Homeostasis and Aneurysmal Disease-Brief Report.
    Galatioto J; Caescu CI; Hansen J; Cook JR; Miramontes I; Iyengar R; Ramirez F
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):588-591. PubMed ID: 29371244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome.
    Dale M; Fitzgerald MP; Liu Z; Meisinger T; Karpisek A; Purcell LN; Carson JS; Harding P; Lang H; Koutakis P; Suh M; Batra R; Mietus CJ; Casale G; Pipinos I; Baxter BT; Xiong W
    PLoS One; 2017; 12(10):e0186603. PubMed ID: 29040313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan Attenuates Degradation of Aorta and Lung Tissue Micromechanics in a Mouse Model of Severe Marfan Syndrome.
    Lee JJ; Galatioto J; Rao S; Ramirez F; Costa KD
    Ann Biomed Eng; 2016 Oct; 44(10):2994-3006. PubMed ID: 27090893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
    Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
    J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox Dysregulation of Vascular Smooth Muscle Sirtuin-1 in Thoracic Aortic Aneurysm in Marfan Syndrome.
    Budbazar E; Sulser Ponce De Leon S; Tsukahara Y; Liu H; Huangfu Y; Wang Y; Seabra PM; Yang X; Goodman JB; Wan X; Chitalia V; Han J; Seta F
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e339-e357. PubMed ID: 37288573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIPK2 Alleviates Thoracic Aortic Disease in Mice With Progressively Severe Marfan Syndrome.
    Caescu CI; Hansen J; Crockett B; Xiao W; Arnaud P; Spronck B; Weinberg A; Hashimoto T; Murtada SI; Borkar R; Gallo JM; Jondeau G; Boileau C; Humphrey JD; He JC; Iyengar R; Ramirez F
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2483-2493. PubMed ID: 34320838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated Marfan syndrome model recapitulates established signaling pathways.
    Gensicke NM; Cavanaugh NB; Andersen ND; Huang T; Qian L; Dyle MC; Turek JW
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1719-1726. PubMed ID: 31272746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm.
    Pedroza AJ; Tashima Y; Shad R; Cheng P; Wirka R; Churovich S; Nakamura K; Yokoyama N; Cui JZ; Iosef C; Hiesinger W; Quertermous T; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2195-2211. PubMed ID: 32698686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome.
    Xiong W; Meisinger T; Knispel R; Worth JM; Baxter BT
    Circ Res; 2012 Jun; 110(12):e92-e101. PubMed ID: 22550139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Fat Diet Has a Protective Sex-Dependent Effect on Aortic Aneurysm Severity in a Marfan Syndrome Mouse Model.
    Lau C; Muthu ML; Siddiqui IF; Li L; Reinhardt DP
    Can J Cardiol; 2023 Nov; 39(11):1553-1567. PubMed ID: 37482239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
    Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
    Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
    J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.